Who we are

BioCurate is a bold, collaborative venture, dedicated to translating Australia’s research potential to drive economic returns and health impacts worldwide. Created jointly by two of Australia’s leading biomedical universities – the University of Melbourne and Monash University – with the support of the Victorian government, we identify promising biomedical research and help accelerate its development into new therapies. We are operationally independent, with a team that brings decades of scientific and commercial expertise, enabling us to recognise and realise real-world potential and providing a critical bridge, aligning the efforts and interests of industry and academia.
We can help you change the future.

We bridge the gap

Our collaborative team of global biomedical experts bridge the gap between:

Academia + Industry
Ideas + Impact
Discovery + Partnerships
Collaboration + Commercialisation
Research + Translation

What we are doing

The BioCurate team

Our team

200
Has over 200 years of combined biotech/pharma industry experience

39
Has been directly involved in over 39 Investigational New Drug applications (INDs)

72
Are responsible for 72 therapeutics currently in the clinic

$3.9B
Were directly involved in 15 deals worth a cumulative total of more than $3.9 billion

Twitter feed

BioCurate recently added 3 new team members, enabling us to more effectively manage those projects within the portfolio that are making significant progress, as well as giving us greater potential to take on additional projects. Read more about our growth https://app.nuvi.com/n/slzha7

BioCurate welcomes the new report by @acola_aus that provides the evidence base to support further investment in science and research infrastructure, skills, talent attraction and industry-led innovation to build a strong economy. Read the report via https://bit.ly/33uZ8KF

BioCurate CEO Dr @cglennbegley will be speaking at #BioConnectionsAus this year. Register now to hear Glenn and fellow sector leaders across industry and academia discuss translation and commercialisation in Australia https://app.nuvi.com/n/gjpay7

For academic researchers in the early stages of drug discovery, understanding the ethos, the attitudes and processes that comprise industry best practice will ready them for the commercialisation journey. What does this entail? Read more https://app.nuvi.com/n/rjlpw8